
Last updated: about 1 month ago
Coursera, Inc. SEC Filing Report: Financial Insights & Stock Recommendation
Explore Coursera's latest SEC filing revealing a $694.67M revenue, a hold stock rating, and positive growth outlook across segments.
Explore Coursera's latest SEC filing revealing a $694.67M revenue, a hold stock rating, and positive growth outlook across segments.
Discover key insights from Amicus Therapeutics' 2024 10-K Report, detailing revenue growth, financial health, and investment strategies. Current stock recommendation: Hold.
Explore DoorDash's financial analysis highlighting revenue growth, shifting profitability, and operational challenges. Key insights recommend holding stock amidst competitive pressures.
Explore Applied DNA Sciences, Inc.'s Q4 2023 financial results, highlighting revenue drops, a net loss, workforce reduction, and strategic shifts. Stock recommendation: Hold.